Journal of Clinical Oncology | 2019
Contemporary therapy efficacy for high-risk multiple myeloma: A systematic review.
Abstract
e19536Background: Multiple Myeloma (MM) is a heterogeneous disease. High Risk (HR) MM is defined as the presence of abnormal cytogenetics i.e. t(4:14), t(14:16), t(14:20), del(17/17p), non hyperdip...